Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1730)
All Articles published online
|
Jun 14, 2007 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sène D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N, Piette JC, Hoang PL, Cacoub P. Intraocular complications of IFN-α and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 2007; 13(22): 3137-3140 [PMID: 17589934 DOI: 10.3748/wjg.v13.i22.3137] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i22/3137.htm |
| Number | Citing Articles |
| 1 |
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot, Alexa Simon Meara. Ocular side effects of antirheumatic medications: a qualitative review. BMJ Open Ophthalmology 2020; 5(1): e000331 doi: 10.1136/bmjophth-2019-000331
|
| 2 |
Maria de Lourdes Arellanes-García, Luz Elena Concha-del-Río, Maria del Carmen Preciado-Delgadillo, Claudia Recillas-Gipsert. Retinal and Choroidal Manifestations of Selected Systemic Diseases. 2013; : 353 doi: 10.1007/978-1-4614-3646-1_19
|
| 3 |
Wang Fang, Peizeng Yang. Vogt-Koyanagi-Harada Syndrome. Current Eye Research 2008; 33(7): 517 doi: 10.1080/02713680802233968
|
| 4 |
Chien‐Hsiung Lai, Yao‐Hsu Yang, Pau‐Chung Chen, Ying‐Chi King, Chia‐Yen Liu. Retinal vascular complications associated with interferon‐ribavirin therapy for chronic hepatitis C: A population‐based study. Pharmacoepidemiology and Drug Safety 2018; 27(2): 191 doi: 10.1002/pds.4363
|
| 5 |
J.P. Salgado, R. Khoramnia, M.M. Maier, C.P. Lohmann, C. Winkler von Mohrenfels. Akute Visusminderung während der Therapie einer chronischen Hepatitis C. Der Ophthalmologe 2011; 108(6): 561 doi: 10.1007/s00347-010-2327-0
|
| 6 |
Fatih Selcukbiricik, Deniz Tural, Tuba Elif Senel, Ahmet Sarıca, Ozlem Soyluk, Suheyla Serdengecti. Bilateral Ischemic Optic Neuropathy Developed under Interferon Therapy. Case Reports in Ophthalmological Medicine 2012; 2012: 1 doi: 10.1155/2012/102739
|
| 7 |
|
| 8 |
G. Pérez-Carro, R. Fernández-Alonso, M.L. González-Diéguez, M. Rodríguez-García, J. Junceda-Moreno. Toxicidad por interferón alfa y neuropatía óptica bilateral reversible: una retirada a tiempo. Archivos de la Sociedad Española de Oftalmología 2014; 89(4): 146 doi: 10.1016/j.oftal.2012.09.007
|
| 9 |
G. Pérez-Carro, R. Fernández-Alonso, M.L. González-Diéguez, M. Rodríguez-García, J. Junceda-Moreno. Interferon-alpha toxicity and reversible bilateral optical neuropathy: A timely withdrawal of the drug. Archivos de la Sociedad Española de Oftalmología (English Edition) 2014; 89(4): 146 doi: 10.1016/j.oftale.2014.06.007
|
| 10 |
Current World Literature. Current Opinion in Ophthalmology 2008; 19(6): 541 doi: 10.1097/ICU.0b013e328317c7c4
|
| 11 |
Vincenza Calvaruso, Marta Mazza, Piero L Almasio. Pegylated-interferon-α2ain clinical practice: how to manage patients suffering from side effects. Expert Opinion on Drug Safety 2011; 10(3): 429 doi: 10.1517/14740338.2011.559161
|
| 12 |
Sohan Singh Hayreh. Ocular Vascular Occlusive Disorders. 2015; : 239 doi: 10.1007/978-3-319-12781-1_13
|
| 13 |
N. Kabbaj, S. Sentissi, M. Mohammadi, A. Benaïssa, N. Amrani. Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC. Gastroentérologie Clinique et Biologique 2009; 33(2): 115 doi: 10.1016/j.gcb.2008.12.004
|
| 14 |
Hassan Seddik, Mouna Tamzaourte, Fadoua Rouibaa, Maha Fadlouallah, Ahmed Benkirane. Irreversible Anterior Ischemic Optic Neuropathy Complicating Interferon Alpha and Ribaverin Therapy. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/814242
|
| 15 |
Ernesto Strobbe, Mauro Cellini, Emilio C. Campos. Aqueous Flare and Choroidal Thickness in Patients with Chronic Hepatitis C Virus Infection. Ophthalmology 2013; 120(11): 2258 doi: 10.1016/j.ophtha.2013.03.040
|
| 16 |
G Brook, J Main, M Nelson, S Bhagani, E Wilkins, C Leen, M Fisher, Y Gilleece, R Gilson, A Freedman, R Kulasegaram, K Agarwal, C Sabin, C Deacon‐Adams. British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010. HIV Medicine 2010; 11(1): 1 doi: 10.1111/j.1468-1293.2009.00781.x
|
| 17 |
Peng-Tai Tien, Chun-Ju Lin, Yi-Yu Tsai, Huan-Sheng Chen, De-Kuang Hwang, Chih-Hsin Muo, Jane-Ming Lin, Wen-Lu Chen. RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS. Retina 2016; 36(12): 2391 doi: 10.1097/IAE.0000000000001103
|
| 18 |
Hande Celiker, Haluk Kazokoglu, Haner Direskeneli. Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet’s Uveitis: A Small Case Series. Ocular Immunology and Inflammation 2019; 27(1): 15 doi: 10.1080/09273948.2017.1332768
|
| 19 |
S. Iferkhass, F. Elasri, S. Chatioui, A. Khoyaali, T. Bargach, K. Reda, A. Oubaaz. Neuropathie optique ischémique non artéritique bilatérale au cours du traitement de l’hépatite virale C par l’association interféron pégylé et Ribavirine®. Journal Français d'Ophtalmologie 2015; 38(1): 34 doi: 10.1016/j.jfo.2014.06.008
|
| 20 |
C. Burgueño-Montañés, R. Pérez-Álvarez. Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C. Archivos de la Sociedad Española de Oftalmología (English Edition) 2011; 86(6): 193 doi: 10.1016/j.oftale.2010.12.003
|
| 21 |
Abdulrahman M. Al-Muammar, Tariq M. Al-Mudhaiyan, Mohammed Al Otaibi, Ayman Abdo, Ahmed M. Abu El-Asrar. Vogt–Koyanagi–Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. International Ophthalmology 2010; 30(5): 611 doi: 10.1007/s10792-010-9357-0
|
| 22 |
F.W. Fraunfelder, F.T. Fraunfelder. Interferon Alfa-associated Anterior Ischemic Optic Neuropathy. Ophthalmology 2011; 118(2): 408 doi: 10.1016/j.ophtha.2010.03.063
|
| 23 |
KASL clinical practice guidelines: Management of Hepatitis C. Clinical and Molecular Hepatology 2014; 20(2): 89 doi: 10.3350/cmh.2014.20.2.89
|
| 24 |
Ina Kötter, Vedat Hamuryudan, Zafer E Öztürk, Hasan Yazici. Interferon therapy in rheumatic diseases: state-of-the-art 2010. Current Opinion in Rheumatology 2010; 22(3): 278 doi: 10.1097/BOR.0b013e3283368099
|
| 25 |
Zeinb A. Hassan, Manal Reda Abd El-Haleem, Mona G. Amer. The structure of the optic nerve after the administration of interferon α-2a in adult male albino rats and the role of α-lipoic acid supplementation. The Egyptian Journal of Histology 2012; 35(2): 209 doi: 10.1097/01.EHX.0000413360.30968.09
|
| 26 |
Ken Sato, Yuichi Yamazaki, Takeshi Kobayashi, Satoshi Takakusagi, Norio Horiguchi, Satoru Kakizaki, Masayasu Andou, Yoshihiro Matsuda, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto. Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature. World Journal of Clinical Cases 2019; 7(9): 1043-1052 doi: 10.12998/wjcc.v7.i9.1043
|
| 27 |
Stela Vujosevic, Diego Tempesta, Franco Noventa, Edoardo Midena, Giada Sebastiani. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening. Hepatology 2012; 56(2): 455 doi: 10.1002/hep.25654
|
| 28 |
A. Such Díaz, N. Barrueco, C. Esteban Alba, I. Escobar Rodríguez. Trombosis venosa retiniana asociada a peginterferón alfa 2b más ribavirina en un paciente con hepatitis C crónica. Farmacia Hospitalaria 2011; 35(2): 93 doi: 10.1016/j.farma.2010.01.010
|
| 29 |
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble, C. Stephen Foster. Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity Reviews 2016; 15(8): 809 doi: 10.1016/j.autrev.2016.04.001
|
| 30 |
Michael R Narkewicz, Philip Rosenthal, Kathleen B Schwarz, Arlene Drack, Todd Margolis, Michael X Repka. Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 183 doi: 10.1097/MPG.0b013e3181b99cf0
|
| 31 |
Jian-Qing Yang, Guang-Dong Pan, Guang-Ping Chu, Zhen Liu, Qiang Liu, Yi Xiao, Lin Yuan. Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein. World Journal of Gastroenterology 2008; 14(36): 5564-5569 doi: 10.3748/wjg.14.5564
|
| 32 |
Ghazala A. Datoo O'Keefe, Narsing A. Rao. Vogt-Koyanagi-Harada disease. Survey of Ophthalmology 2017; 62(1): 1 doi: 10.1016/j.survophthal.2016.05.002
|
| 33 |
Hee Young Kang, Ji Won Lim, Min Chul Shin. Pegylated Interferon Associated Retinopathy in Chronic Hepatitis Patients. Journal of the Korean Ophthalmological Society 2009; 50(3): 383 doi: 10.3341/jkos.2009.50.3.383
|
| 34 |
Laurent Ballonzoli, Tristan Bourcier. Complications ophtalmologiques des immunosuppresseurs et des corticoïdes. Therapies 2010; 65(2): 115 doi: 10.2515/therapie/2010002
|
| 35 |
O. Leaman-Alcibar, F. López-Campos, J. Aller, Ana Calín-Lorca, E. Zatarain-Nicolás, M. F. Bande, A. Navarro-Martin. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_339-1
|
| 36 |
Frederick “Fritz” T. Fraunfelder, Frederick “Rick” W. Fraunfelder. Drug-Induced Ocular Side Effects. 2021; : 299 doi: 10.1016/B978-0-323-65375-6.00015-3
|
| 37 |
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi, Jay Chhablani. Retinal toxicities of systemic anticancer drugs. Survey of Ophthalmology 2022; 67(1): 97 doi: 10.1016/j.survophthal.2021.05.007
|
| 38 |
Madhura A. Tamhankar. Liu, Volpe, and Galetta's Neuro-Ophthalmology. 2019; : 53 doi: 10.1016/B978-0-323-34044-1.00004-3
|
| 39 |
C. Burgueño-Montañés, R. Pérez-Álvarez. Retinopatía asociada a interferón pegilado y ribavirina en pacientes con hepatitis C. Archivos de la Sociedad Española de Oftalmología 2011; 86(6): 193 doi: 10.1016/j.oftal.2010.12.015
|
| 40 |
N. Ailem, G. Gendron, I. De Monchy, N. Lecuen, R. Tahiri, H. Offret, M. Labetoulle. 591 Neuropathies optiques au cours du traitement par interféron alpha. Journal Français d'Ophtalmologie 2009; 32: 1S178 doi: 10.1016/S0181-5512(09)73715-5
|
| 41 |
Antoinette Day, Amanda K. Abramson, Mahir Patel, Richard B. Warren, M. Alan Menter. The spectrum of oculocutaneous disease. Journal of the American Academy of Dermatology 2014; 70(5): 821.e1 doi: 10.1016/j.jaad.2013.12.019
|
| 42 |
Kathleen T Berg, Bruce Nelson, Andrew R Harrison, Linda K McLoon, Michael S Lee. Pegylated Interferon Alpha-Associated Optic Neuropathy. Journal of Neuro-Ophthalmology 2010; 30(2): 117 doi: 10.1097/WNO.0b013e3181d8e4af
|
| 43 |
Masaaki Watanabe, Sumie Ogasawara, Akihiko Takahashi, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Wasaburo Koizumi. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. Cutaneous and Ocular Toxicology 2012; 31(3): 253 doi: 10.3109/15569527.2011.641197
|
| 44 |
Guillaume Mellon, Hind Stitou, Roland Tubiana, Marc Antoine Valantin, François Bricaire, Olivier Aoun, Vincent Thibault. Lateral rectus muscle paralysis induced by ribavirin and pegylated interferon-α2a in a patient with HIV/HCV co-infection. Journal of Infection and Chemotherapy 2012; 18(6): 937 doi: 10.1007/s10156-012-0383-x
|
| 45 |
Xiaoli Liu, Maria Diedrichs-Möhring, Gerhild Wildner. The Role of IFN-alpha in Experimental and Clinical Uveitis. Ocular Immunology and Inflammation 2019; 27(1): 23 doi: 10.1080/09273948.2017.1298822
|
| 46 |
Yi-Hsuan Wei, I-Hua Wang, Lin-Chung Woung, Jieh-Ren Jou. Anterior Ischemic Optic Neuropathy Associated with Pegylated Interferon Therapy for Chronic Hepatitis C. Ocular Immunology and Inflammation 2009; 17(3): 191 doi: 10.1080/09273940802687820
|
| 47 |
Grant T. Liu, Nicholas J. Volpe, Steven L. Galetta. Neuro-Ophthalmology. 2010; : 55 doi: 10.1016/B978-1-4160-2311-1.00004-4
|
| 48 |
A. Chebil, F. Kort, R. Bouraoui, N. Ben Youssef, L. El Matri. Syndrome de Vogt-Koyanagi-Harada au cours d’une hépatite C chronique sous interféron alpha et ribavirine. Journal Français d'Ophtalmologie 2010; 33(3): 185 doi: 10.1016/j.jfo.2010.01.009
|
| 49 |
Nicole K. Scripsema, Emile Sharifi, C. Michael Samson, Sanjay Kedhar, Richard B. Rosen. CHIKUNGUNYA-ASSOCIATED UVEITIS AND EXUDATIVE RETINAL DETACHMENT. RETINAL Cases & Brief Reports 2015; 9(4): 352 doi: 10.1097/ICB.0000000000000232
|
| 50 |
Zubir S. Rentiya, Matthew Wells, Junun Bae, Kuan-Jen Chen, An-Ning Chao, Nicholas Turgeon, Syed M. Shah, Mostafa Hanout. Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations. Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257(3): 447 doi: 10.1007/s00417-018-04209-7
|
| 51 |
Nikki Y. Far, David T. L. Liu. Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier. Journal of Ophthalmic Inflammation and Infection 2012; 2(4): 235 doi: 10.1007/s12348-012-0082-x
|
| 52 |
Valerio Pazienza. Ophthalmological complications in hepatitis C virus infection: Side effect of interferon therapy or a direct role of HCV?. Biomedicine & Pharmacotherapy 2011; 65(4): 317 doi: 10.1016/j.biopha.2011.04.004
|